Fesoterodine Uses, Dosage, Side Effects and Interactions
Toviaz
Toviaz was the first fesoterodine product the FDA approved, in October 2008. An FDA-approved generic with the same active ingredient is listed.
Fesoterodine is a bladder-calming medicine (an antimuscarinic) used to treat overactive bladder in adults and, in some products, neurogenic detrusor overactivity (bladder overactivity caused by a nerve problem) in children 6 and older.
Quick links
Ask Anything About FesoterodineType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Fesoterodine in Short
What it treatsFesoterodine treats overactive bladder (OAB) in adults. That means symptoms like urge urinary incontinence (leaking with a sudden urge), urgency, and frequency. Some products are also approved for neurogenic detrusor overactivity (NDO) in children 6 years and older who weigh more than 25 kg.
- How you get it Prescription only
- Comes asExtended-release tablet (by mouth)
- Crushing or chewingSome forms are on our Do Not Crush list Listed: Fesoterodine fumarate (tablet, extended release); Toviaz (tablet, extended release)
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- Supplements and herbs200 interact 9 major, 150 moderate and 41 minor
- What pharmacies pay
- Generic$0.73 to $0.90 a tablet
- Toviaz (brand)$9.26 to $9.29 a tablet
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Fesoterodine (Toviaz) is an antimuscarinic, a drug that blocks the nerve signals telling the bladder muscle to squeeze so it holds more. It is one of the standard medicines for overactive bladder in adults, and some products also treat neurogenic detrusor overactivity (bladder overactivity from a nerve problem) in children 6 and older who weigh over 25 kg. It has been on the U.S. market since about 2008, and FDA-approved generics are listed. Most people tolerate it reasonably well, and dry mouth is the side effect people notice most, followed by constipation. Stop it and get emergency help for any swelling of the face, lips, tongue, or throat (angioedema), which can appear after the first dose or days later.
Key Takeaways From the HelloPharmacist Team
- Take it once a day with liquid, with or without food, and swallow the extended-release tablet whole without chewing, splitting, or crushing it.
- Give it a few weeks before judging it, since bladder control usually improves gradually rather than overnight.
- Call your prescriber if passing urine gets harder or the stream turns weak, since your bladder may not be emptying.
- Skip driving until you know whether it makes you drowsy or dizzy, especially after starting or raising the dose.
Patient Information Guide for Fesoterodine
What It’s Used For
Fesoterodine is used for bladder conditions across several products.
- Overactive bladder (OAB) in adults, with urge urinary incontinence, urgency, and frequency. This applies to all supported fesoterodine fumarate extended-release tablet labels and to Toviaz.
- Neurogenic detrusor overactivity (NDO) in children 6 and older weighing over 25 kg. This is listed for Toviaz and one fesoterodine fumarate film-coated extended-release tablet label, not for the other tablet label.
How It Works
Fesoterodine is a muscarinic receptor blocker. After you swallow it, the body quickly converts it to its active form, 5-hydroxymethyl tolterodine. Muscarinic receptors help make the bladder muscle contract. Blocking them in the bladder is believed to calm those contractions.
Drug Class
WHO drug family
- Drugs for urinary frequency and incontinence
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)None. The FDA’s index lists no class of any kind for Fesoterodine.
The main drug class the FDA gives it. It is the class named on the drug’s label.
What It Does in the Body
Physiologic effect (PE)None listed for Fesoterodine in the FDA’s index.
From our Patient Information GuideFesoterodine is a muscarinic receptor blocker. After you swallow it, the body quickly converts it to its active form, 5-hydroxymethyl tolterodine. Muscarinic receptors help make the bladder muscle contract. Read How Fesoterodine Works
A change it makes in how the body works.
Drug Family
WHO ATC classification- Drugs for urinary frequency and incontinence
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification, from the U.S. National Library of Medicine’s RxClass. Reference only, not medical advice.
Dosage
Fesoterodine is an extended-release tablet taken by mouth once a day.
- Swallow it whole with liquid. Do not chew, divide, or crush it.
- Take it with or without food.
- Your prescriber may start low and increase the dose based on response and tolerability. Kidney function, certain other medicines, and a child's weight can change the dose.
Follow your prescriber and the product label.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Overactive bladder
Adults Starting dose 4 mg once a day Highest dose 8 mg once a day
- Based upon individual response and tolerability, increase to 8 mg once daily
What overactive bladder is: A sudden, hard-to-control urge to urinate, often with going more often than usual.
Adults taking strong CYP3A4 inhibitors Highest dose 4 mg once a day
- Maximum recommended dosage 4 mg orally once daily
Good to know
Strong CYP3A4 inhibitors
Adults with kidney problems (CLcr 30 to 89 mL/min) Usual dose 8 mg once a day
Good to know
Estimated using Cockcroft-Gault formula
CrCl means creatinine clearance, a measure of how well the kidneys work.
Adults with kidney problems (CLcr 15 to 29 mL/min) Usual dose 4 mg once a day
Good to know
Estimated using Cockcroft-Gault formula
CrCl means creatinine clearance, a measure of how well the kidneys work.
People with kidney problems Usual dose 4 mg once a day
Good to know
Estimated using Cockcroft-Gault formula
Bladder control problems from a nerve condition (neurogenic detrusor overactivity)
Children 6 years and older weighing more than 25 kg and up to 35 kg Usual dose 4 mg once a day Highest dose 8 mg once a day
- If needed, may be increased to 8 mg orally once daily
Children 6 years and older weighing more than 35 kg Starting dose 4 mg once a day Usual dose 8 mg once a day Highest dose 8 mg once a day
- After one week, increase to 8 mg orally once daily
Children weighing more than 35 kg taking strong CYP3A4 inhibitors Highest dose 4 mg once a day
- Maximum recommended dosage 4 mg orally once daily
Good to know
Strong CYP3A4 inhibitors
People with kidney problems and children and weighing greater than 25 kg and up to 35 kg with , eGFR 30 to 89 mL/min/1.73m Usual dose 4 mg once a day
eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.
People with kidney problems and children and weighing greater than 25 kg and up to 35 kg with , eGFR 15 to 29 mL/min/1.73m Use is Not Recommended
eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.
Children weighing more than 35 kg with kidney problems (eGFR 30 to 89) Starting dose 4 mg once a day Usual dose 8 mg once a day
- After one week, increase to 8 mg orally once daily
eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.
Children weighing more than 35 kg with kidney problems (eGFR 15 to 29) Usual dose 4 mg once a day
eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.
People on dialysis · Pediatric patients weighing greater than 35 kg with renal impairment, eGFR <15 mL/min/1.73m2 or requiring dialysis Use is Not Recommended
eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.
Side Effects
Most side effects are related to the drug's drying, anticholinergic effects.
Common side effects
- Dry mouth (the most common)
- Constipation
- Indigestion or upset stomach
- Nausea
- Dry eyes
- Urinary tract infection
- Painful urination
- Dry throat or cough
- In children: diarrhea, stomach pain, headache, weight gain, and some vision effects such as blurred vision
When to get medical help
- Swelling of the face, lips, tongue, or throat (angioedema) can be life-threatening. Get emergency help and stop the medicine.
- Trouble passing urine or a weak or blocked urine stream.
- Severe constipation or signs your stomach or gut is slowing down.
- Eye pain or vision changes if you have narrow-angle glaucoma.
- Marked sleepiness, dizziness, or headache, especially after starting or raising the dose.
- Worsening muscle weakness if you have myasthenia gravis.
- Fast heartbeat, palpitations, or chest pain.
Get urgent help for swelling of the face, lips, tongue, or throat, or if you cannot pass urine. Also report severe constipation or marked sleepiness.
Warnings and Precautions
- Angioedema: swelling of the face, lips, tongue, or throat. It can be life-threatening and may happen after the first dose or later.
- Urinary retention: not recommended with significant bladder outlet obstruction, and contraindicated with urinary retention.
- Slowed gut: contraindicated with gastric retention and not recommended with severe constipation.
- Narrow-angle glaucoma: contraindicated if uncontrolled. Use with caution if treated.
- Drowsiness and dizziness: avoid driving until you know how it affects you.
- Myasthenia gravis: may worsen symptoms.
- Heart rate: it can raise heart rate, especially at higher doses and in children.
Interactions
Some medicines change fesoterodine levels or add to its side effects.
- Other antimuscarinic drugs: can increase dry mouth, constipation, and urinary retention.
- Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin): raise levels of the active form, so the dose is limited.
- Rifampin: lowers levels of the active form, but no dose change is recommended.
- Moderate CYP3A4 inhibitors, including grapefruit juice: no dose change needed.
- Warfarin and combined birth control pills: no significant effect found.
Interactions Listed in the FDA-Approved Label
From the Fesoterodine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Other antimuscarinic drugsWhat happensCoadministration with other antimuscarinic agents that produce dry mouth, constipation, urinary retention and other anticholinergic effects may increase the frequency and/or severity of such effects; anticholinergics may alter absorption of some drugs.
-
Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin)What happensKetoconazole led to approximately a doubling of Cmax and AUC of the active metabolite 5-HMT.What to doDoses greater than 4 mg are not recommended in adults; in children, reduce to 4 mg once daily if over 35 kg, and not recommended for 25 kg up to 35 kg.
-
Moderate CYP3A4 inhibitors (erythromycin, fluconazole, diltiazem, verapamil, grapefruit juice)What happensNo clinically relevant effect on fesoterodine pharmacokinetics.What to doNo dosing adjustments are recommended.
-
Weak CYP3A4 inhibitors For example: cimetidineWhat happensEffect was not examined; not expected to exceed the effect of moderate inhibitors.
-
CYP3A4 inducers (rifampin, carbamazepine)What happensRifampin decreased Cmax and AUC of the active metabolite by approximately 70% and 75%.What to doNo dosing adjustments are recommended.
-
CYP2D6 inhibitorsWhat happensNot tested clinically; in CYP2D6 poor metabolizers Cmax and AUC of the active metabolite are increased 1.7- and 2-fold.What to doNo dosing adjustments are recommended.
-
Drugs metabolized by cytochrome P450What happensAt therapeutic concentrations the active metabolite does not have the potential to inhibit or induce Cytochrome P450 enzyme systems.
-
Oral contraceptives (ethinyl estradiol and levonorgestrel)What happensNo clinically significant changes in plasma concentrations of the contraceptives.
-
What happensFesoterodine 8 mg once daily has no significant effect on the pharmacokinetics or anticoagulant activity (PT/INR) of warfarin 25 mg.What to doStandard therapeutic monitoring for warfarin should be continued.
-
Laboratory testsWhat happensInteractions with laboratory tests have not been studied.
Read the label’s full interactions text
7 DRUG INTERACTIONS 7.1 Antimuscarinic Drugs Coadministration of fesoterodine fumarate extended-release tablets with other antimuscarinic agents that produce dry mouth, constipation, urinary retention, and other anticholinergic pharmacological effects may increase the frequency and/or severity of such effects. Anticholinergic agents may potentially alter the absorption of some concomitantly administered drugs due to anticholinergic effects on gastrointestinal motility. 7.2 CYP3A4 Inhibitors Doses of fesoterodine fumarate extended-release tablets greater than 4 mg are not recommended in adult patients taking strong CYP3A4 inhibitors, such as ketoconazole, itraconazole, and clarithromycin. The fesoterodine fumarate extended-release tablets dose in pediatric patients taking strong CYP3A4 inhibitors is recommended to be reduced to 4 mg once daily in patients >35 kg and is not recommended in patients weighing greater than 25 kg and up to 35 kg. In a study in adults, coadministration of the strong CYP3A4 inhibitor ketoconazole with fesoterodine led to approximately a doubling of the maximum concentration (C max ) and area under the concentration versus time curve (AUC) of 5-hydroxymethyl tolterodine (5-HMT), the active metabolite of fesoterodine. Compared with CYP2D6 extensive metabolizers not taking ketoconazole, further increases in the exposure to 5-HMT were observed in subjects who were CYP2D6 poor metabolizers taking ketoconazole. There is no clinically relevant effect of moderate CYP3A4 inhibitors on the pharmacokinetics of fesoterodine. Following blockade of CYP3A4 by coadministration of the moderate CYP3A4 inhibitor fluconazole 200 mg twice a day for 2 days, the average (90% confidence interval) increase in C max and AUC of the active metabolite of fesoterodine was approximately 19% (11% to 28%) and 27% (18% to 36%) respectively.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Allergy to fesoterodine, its ingredients, or tolterodine
- Urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma
- Bladder outlet obstruction, severe constipation, or myasthenia gravis
- Kidney impairment, which may need a dose change
- Pregnancy: no human data, and animal studies showed fetal harm at high exposures
- Breastfeeding: no information on milk transfer
- Children: approved only for NDO at age 6 and older and over 25 kg
- Adults 75 and older: more likely to have antimuscarinic side effects
Overdose
Too much fesoterodine can cause severe anticholinergic effects. Treatment is symptom-based and supportive, and ECG (heart rhythm) monitoring is recommended. Contact poison control or seek emergency care right away.
Half-Life and How Your Body Processes It
Fesoterodine is well absorbed and is quickly converted to its active form, which reaches peak levels in about 5 hours. Food has no clinically relevant effect. The liver breaks it down using CYP2D6 and CYP3A4, and the kidneys remove much of it. The effective half-life is about 7 hours after oral dosing. People who are CYP2D6 poor metabolizers have about twice the exposure.
Storage
Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) . Protect from moisture.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Fesoterodine
From the licensed clinical database we use, rolled up per supplement, most serious first.200 supplements and herbal products have documented interactions with Fesoterodine in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 9Major
- 150Moderate
- 41Minor
- 1,4-BUTANEDIOLMajor
- ACTIVATED CHARCOALMajor
- BEERMajor
- GAMMA-HYDROXYBUTYRATE (GHB)Major
- GRAPEFRUITMajor
- KAVAMajor
- L-TRYPTOPHANMajor
- ST. JOHN'S WORTMajor
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Fesoterodine: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Fesoterodine — the kind of thing our pharmacy team would talk through with you at the counter.
What is fesoterodine for?
How do I take it?
What side effects should I expect?
When should I get emergency help?
Can I drive on it?
Do other medicines matter?
Is fesoterodine available over the counter?
When was fesoterodine first available?
Who makes fesoterodine?
What is the brand name of fesoterodine?
What is the generic name of Toviaz?
Is there a generic version of fesoterodine?
What strengths does fesoterodine come in?
How much does fesoterodine cost?
Is there a fesoterodine shortage?
Where can I read the fesoterodine prescribing information (package insert)?
Can you crush fesoterodine?
Is fesoterodine gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Fesoterodine
Skip the scrolling. Ask in your own words and get an answer from Fesoterodine’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Fesoterodine’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Fesoterodine on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Fesoterodine Forms and Strengths (How It Comes)
Fesoterodine comes in 1 dose form, the extended-release tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Fesoterodine inactive ingredients by manufacturer.
Extended-release tablet
How this form is used
- Fesoterodine Fumarate extended-release tablets treat overactive bladder in adults.
- Toviaz treats overactive bladder in adults.
- Toviaz also treats neurogenic detrusor overactivity in children 6 and older weighing over 25 kg.
- One fesoterodine fumarate film-coated extended-release tablet label also lists neurogenic detrusor overactivity in children 6 and older weighing over 25 kg.
- Fesoterodine fumarate film-coated extended-release tablets are taken by mouth once daily.
- Swallow whole with liquid. Do not chew, divide, or crush.
- Fesoterodine fumarate film-coated extended-release tablets can be taken with or without food.
- Follow your prescriber and the product label for dosing.
Fesoterodine on the U.S. Market: Products, Makers and Brands
How Fesoterodine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
12 companies list 24 Fesoterodine product records with the FDA, mostly as extended-release tablet; the earliest marketing or approval year on record is 2008. The one brand name in the directory today is Toviaz; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (7) · Unfinished tablet, extended release (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Fesoterodine Is Used (Medicaid Data)
How many Fesoterodine prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Fesoterodine prescribed? Of the 1,682 medications we measure, Fesoterodine ranks #785 by Medicaid prescriptions — more than 53% of them.
Utilization by Fesoterodine product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet Most dispensed
8 of 34 listed NDCs had Medicaid claims. RxNorm 810077
24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet
8 of 33 listed NDCs had Medicaid claims. RxNorm 810071
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 16 of the 67 listed Fesoterodine NDCs had Medicaid claims.
Compare Fesoterodine Products
A representative set of FDA-listed product records for Fesoterodine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Extended-release tablet | ||||
| 4 mg | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 8 mg | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 4 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 8 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 4 mg | Oral | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 8 mg | Oral | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 4 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| 8 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| 4 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 8 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 4 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 8 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 4 mg | Oral | Dr.Reddy's Laboratories Inc., | ANDA | View NDC → |
| 8 mg | Oral | Dr.Reddy's Laboratories Inc., | ANDA | View NDC → |
| 4 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 8 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 4 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 8 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 4 mg | Oral | Pfizer Laboratories Div Pfizer Inc | NDA | View NDC → |
| 8 mg | Oral | Pfizer Laboratories Div Pfizer Inc | NDA | View NDC → |
| 4 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 8 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 4 mg | Oral | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 8 mg | Oral | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
Showing 24 of 24 products — FDA National Drug Code Directory. See every product, package size and price: browse all 24 Fesoterodine NDCs →
Fesoterodine Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Fesoterodine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Fesoterodine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Fesoterodine FDA Approval History
How Fesoterodine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Fesoterodine Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list 2 Fesoterodine recalls since July 2021. Both are still ongoing or began in the last six months. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals… Lots: Lot# 2405003360, Exp Date: Jan 31, 2026 FDA record D-0248-2026 →
- Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceut… Lots: Lot # 2405006633, Exp Date: 03/31/2026 FDA record D-0156-2026 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Fesoterodine in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 1
- Strengths
- 2
- Forms in current FDA listings
- 1 of 1
RxCUI 797195 RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Fesoterodine Supply and Shortage Status
Whether Fesoterodine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Fesoterodine Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Fesoterodine: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick the generic or the brand and a strength to see how its price has changed since Nov 2023.
At this strength, Toviaz costs pharmacies $9.29 per tablet.
For the generic 4 mg extended-release tablet, pharmacies paid an average of $0.734 per tablet as of Nov 18, 2026, down 21% from $0.930 a year earlier. At this strength, Toviaz costs pharmacies $9.29 per tablet.
- What pharmacies pay now
- $0.734
- per tablet, as of Nov 18, 2026
- Last 4 weeks
- Down 5.4%
- from $0.777 on Oct 21, 2026
- Last 12 months
- Down 21%
- from $0.930 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $0.649 to $1.14
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $0.734 |
| Oct 2026 | $0.777 |
| Sep 2026 | $0.794 |
| Aug 2026 | $0.791 |
| Jul 2026 | $0.790 |
| Jun 2026 | $0.833 |
| May 2026 | $0.846 |
| Apr 2026 | $0.840 |
| Mar 2026 | $0.824 |
| Feb 2026 | $0.841 |
| Jan 2026 | $0.883 |
| Dec 2025 | $0.909 |
| Nov 2025 | $0.930 |
| Oct 2025 | $0.901 |
| Sep 2025 | $0.878 |
| Aug 2025 | $0.893 |
| Jul 2025 | $0.881 |
| Jun 2025 | $0.882 |
| May 2025 | $0.858 |
| Apr 2025 | $0.864 |
| Mar 2025 | $0.851 |
| Feb 2025 | $0.830 |
| Jan 2025 | $0.788 |
| Dec 2024 | $0.814 |
| Nov 2024 | $0.727 |
| Oct 2024 | $0.918 |
| Sep 2024 | $0.924 |
| Aug 2024 | $0.929 |
| Jul 2024 | $0.649 |
| Jun 2024 | $0.875 |
| May 2024 | $0.908 |
| Apr 2024 | $0.959 |
| Mar 2024 | $1.03 |
| Feb 2024 | $1.05 |
| Jan 2024 | $1.13 |
| Dec 2023 | $1.14 |
| Nov 2023 | $1.06 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Extended-release tablet · Oral | 4 mg | Generic | $0.734 per tablet | NDC details & price history |
| Extended-release tablet · Oral | 4 mg | Toviaz (brand) | $9.29 per tablet | NDC details & price history |
| Extended-release tablet · Oral | 8 mg | Generic | $0.897 per tablet | NDC details & price history |
| Extended-release tablet · Oral | 8 mg | Toviaz (brand) | $9.26 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Fesoterodine Brand Names
Fesoterodine has one brand name on record: Toviaz. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Fesoterodine: Manufacturers and Labelers
12 companies list Fesoterodine products with the FDA. By number of product records, the largest are Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Amneal Pharmaceuticals LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Fesoterodine Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Pfizer Laboratories Div Pfizer Inc is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →